Edwards offers $500 million share repurchase program, continued ...
Edwards bought back a little more than 7 million shares for $402 million between January 2008 and December 2009. The company had 56.6 million shares of common stock at the end of December.
Edwards, which specializes in developing heart valves and hemodynamic monitoring products, also recently reported positive results during its fourth quarter, which ended Dec. 31.
The firm said it garnered net income of about $48 million – which is up from $38 million at the same time in 2008. Edwards also reported a 12 percent jump in net sales – the number hit about $347 million in the period.
Mussallem attributes the growth to the progress Edwards has made on its new technologies, as well as the uptick in U.S. shares in the surgical heart valve therapy market. << PREVIOUS PAGE